Horizon Investment Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Horizon Investment Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,712	Closed	-$2.68M	–	135
2024 Q2	$2.68M	Sell	5,712 -89	-2%	-$38.6K	1.26%	25
2024 Q1	$2.42M	Sell	5,801 -535	-8%	-$226K	1.19%	33
2023 Q4	$2.58M	Buy	6,336 +692	+12%	+$256K	1.39%	25
2023 Q3	$1.96M	Sell	5,644 -58	-1%	-$20.3K	1.18%	31
2023 Q2	$2.01M	Sell	5,702 -30	-0.5%	-$10.1K	1.23%	32
2023 Q1	$1.81M	Buy	5,732 +411	+8%	+$123K	1.16%	30
2022 Q4	$1.54M	Buy	+5,321	New	+$1.62M	1.12%	31

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Horizon Investment Services's VRTX Position: Q3 2024 in Review

Horizon Investment Services sold out of Vertex Pharmaceuticals (VRTX) in Q3 2024, closing a stake of 5,712 shares — an estimated $2.68M sold.

Horizon Investment Services first reported a position in VRTX in Q4 2022 and held it in 7 quarters. The position peaked at $2.68M in Q2 2024. 1,544 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

Horizon Investment Services reported no remaining Vertex Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Horizon Investment Services sold 5,712 Vertex Pharmaceuticals shares in Q3 2024, an estimated $2.68M.
Horizon Investment Services first reported a position in Vertex Pharmaceuticals in Q4 2022 and held it in 7 quarters.
Horizon Investment Services's Vertex Pharmaceuticals position peaked at $2.68M in Q2 2024.
1,544 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on Horizon Investment Services's 13F filing for Q3 2024, filed 12 Nov 2024.